HSP90-dependent PUS7 overexpression facilitates the metastasis of colorectal cancer cells by regulating LASP1 abundance
2021 · Journal of Experimental & Clinical Cancer Research · 62 citations
https://doi.org/10.1186/s13046-021-01951-5
J
Jie Chen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
772
Papers
10.7K
Citations
51
h-index
245
i10-index
Jie Chen is an academic researcher from James Madison University. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Pancreatic and Hepatic Oncology Research & RNA modifications and cancer. The author has an h-index of 51, co-authored 657 publications.
ORCID: 0000-0003-2583-2631Papers by this author
worksLong-term lifestyle interventions in middle-aged and elderly men with nonalcoholic fatty liver disease: a randomized controlled trial
2016 · Scientific Reports · 59 citations
https://doi.org/10.1038/srep36783
Memory T cells skew toward terminal differentiation in the CD8+ T cell population in patients with acute myeloid leukemia
2018 · Journal of Hematology & Oncology · 33 citations
https://doi.org/10.1186/s13045-018-0636-y
Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer – A subgroup analysis of the pivotal NAPOLI-1 trial
2019 · Journal of Geriatric Oncology · 27 citations
https://doi.org/10.1016/j.jgo.2019.02.011
A novel bispecific antibody drug conjugate targeting HER2 and HER3 with potent therapeutic efficacy against breast cancer
2024 · Acta Pharmacologica Sinica · 27 citations
https://doi.org/10.1038/s41401-024-01279-8
Efficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer: a multicenter, single-arm, phase II study
2023 · International Journal of Gynecological Cancer · 24 citations
https://doi.org/10.1136/ijgc-2023-004705
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat